GENE ONLINE|News &
Opinion
Blog

Partnerships
CSL Promises $4 Billion In Biobucks For Arcturus’ Self-Amplifying mRNA Vaccines
2022-11-03
Exelixis, Cybrexa Pen $700 Million Deal Over Peptide-Drug Conjugate
2022-11-02
Thermo Fisher Announces $59 Million Lab Expansion In Kentucky, Reveals AI Deal With Genoox
2022-10-28
Research and Development Partnership Between Agilent and Monash University Malaysia Announced
2022-10-26
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
Illumina Teams Up With GenoScreen in Eradicating Tuberculosis
2022-10-19
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
WuXi Biologics, Toregem BioPharma To Develop Tooth-Regenerating Antibody
2022-10-14
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
Sanofi, miRecule To Develop Muscular Dystrophy Candidate In $400+ Million Partnership
2022-10-05
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Allen Institute Launches Next Phase of Mapping the Human Brain With $173 Million
2022-09-23
Spero Accepts GSK’s $66 Million to Save its Rejected Antibiotic
2022-09-23
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
1 3 4 5 6 7
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top